Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s733, 2026. DOI: 10.25251/8r6ert44. Disponível em: https://skin.dermsquared.com/skin/article/view/4026. Acesso em: 27 apr. 2026.